Karnitz, L M <br/><br/>
Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway.  [electronic resource] 

 -  Molecular and cellular biology  Jun 1995 
 - 3049-57 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0270-7306 
<br/><br/><label>Standard No.: </label>10.1128/MCB.15.6.3049  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androstadienes--pharmacology<br/>Cell Cycle--drug effects<br/>Cell Line<br/>Humans<br/>Interleukin-2--metabolism<br/>Mitogen-Activated Protein Kinase Kinases<br/>Phosphatidylinositol 3-Kinases<br/>Phosphotransferases (Alcohol Group Acceptor)--metabolism<br/>Protein Kinases--metabolism<br/>Second Messenger Systems<br/>Signal Transduction<br/>T-Lymphocytes--metabolism<br/>Wortmannin